Key Messages
Complete molecular remission in ‘variant APL’ patient with short isoform
of PML-RARα and FLT3-ITD in response to ATRA and ATO plus IDA. The use
of FLT3 inhibitor in APL induction management could prevent
differentiation syndrome and coagulopathy experienced in the patient.